Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer.

Okugawa, Y; Miki, C; Toiyama, Y; Yasuda, H; Yokoe, T; Saigusa, S; Hiro, J; Tanaka, K; Inoue, Y; Kusunoki, M

Okugawa, Y; Miki, C; Toiyama, Y; Yasuda, H; Yokoe, T; Saigusa, S; Hiro, J; Tanaka, K; Inoue, Y; Kusunoki, M.

Affiliation

Okugawa Y; Division of Reparative Medicine, Department of Gastrointestinal and Pediatric Surgery, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.

Br J Cancer ; 103(6): 787-95, 2010 Sep 07.

Article in En | MEDLINE | ID: mdl-20823887

Subject(s)

Colorectal Neoplasms/metabolism; Receptors, Interleukin-6/metabolism; Base Sequence; Colorectal Neoplasms/pathology; DNA Primers; Disease Progression; Female; HT29 Cells; Humans; Immunohistochemistry; Male

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Receptors, Interleukin-6 Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Br J Cancer Year: 2010 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google